HealthcareNSE · BSE

PIRAMAL PHARMA LIMITED

PPLPHARMA · ISIN INE0DK501011

Share price

₹163▼ -2.81%

Market capitalisation

₹21561 Cr● Closed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹21561 Cr

Current price

₹163

-2.81% today

52W high

₹221

52W low

₹132

Stock P/E

—

P/B ratio

2.51

02 · Per share & returns

EPS (TTM)

-₹2.46

Book value

₹64.78

ROE

-4.00%

ROA

0.34%

Dividend yield

0.08%

Beta

0.39

03 · Financials (TTM)

By the numbers

Revenue

₹8869 Cr

-0.10% YoY

EBITDA

₹875 Cr

Net profit

₹-325.94 Cr

Profit margin

-3.67%

Operating margin

8.80%

Total debt

₹5675 Cr

Total cash

₹1355 Cr

Debt / equity

0.70x

Current ratio

1.51x

Payout ratio

15.07%

04 · Analyst view

Target price

₹203

Upside

+24.92%

Consensus

NONE

Analysts

05 · Shareholding pattern

Who owns PPLPHARMA?

Promoters
34.86%
Founders & promoter group
Institutions
20.98%
FII + DII
Public
44.16%
Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol: PPLPHARMA
Exchange: NSE · BSE
CIN: —
ISIN: INE0DK501011
BSE code: 543635
Sector: Healthcare
Industry: Healthcare
Face value: ₹10
Listing date: 18 Oct 2022
Employees: —
Headquarters: Mumbai, India
Website: www.piramalpharma.com

07 · About

What is PIRAMAL PHARMA LIMITED?

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of PIRAMAL PHARMA LIMITED?+

The Corporate Identity Number for PIRAMAL PHARMA LIMITED is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of PIRAMAL PHARMA LIMITED?+

Promoter holding in PPLPHARMA is approximately 34.86%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of PIRAMAL PHARMA LIMITED?+

PIRAMAL PHARMA LIMITED (PPLPHARMA) has a market capitalisation of approximately ₹21561 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent